However, antibodies with enhanced FcγR engagement activity were ineffective against HIV and shown to augment disease severity in Dengue in vivo due to ADE of infection highlighting the importance of carefully optimizing the IgG-Fc-FcγR interactions depending on the role antibodies play in disease pathogenesis (31, 32). Here, FCGR2A is linked to dengue disease.